openPR Logo
Press release

Personnel changes in the management board of Berlin Heart GmbH

10-24-2014 06:47 PM CET | Health & Medicine

Press release from: Berlin Heart GmbH

Personnel changes in the management board of Berlin Heart GmbH

As of October, 20th 2014 Mr. Sven-René Friedel and Dr. Ares K. Menon are appointed as new members of the management board. In addition to the finance and administration department, Mr. Friedel will be responsible for the departments Research & Development as well as Quality Management & Regulatory Affairs. Dr. Menon will be responsible for the departments Clinical Affairs & Clinical Science, Marketing & Sales, as well as Production. Each of them will continue to operate the company Berlin Heart in the trustworthy manner.
At his own request, Dr. Dirk Lauscher is resigning from his service as general manager of Berlin Heart GmbH on the aforementioned date. The advisory board of Berlin Heart GmbH would like to thank Dr. Lauscher for his commitment and successful cooperation.

About Berlin Heart
Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices (VADs) for patients of every age and body size. The company offers pumps, cannulae, and external components for internal and external use to stabilize cardiac activity in acutely ill patients. Its products are market leaders in their respective segments in Germany and in Europe. The company also manufactures the implantable left ventricular assist device INCOR®, which has been designed for long-term application in adult patients. INCOR® is not FDA-approved, but widely used in Europe.

Contact
Berlin Heart GmbH
Antonia Unger
Wiesenweg 10
12247 Berlin
info@berlinheart.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Personnel changes in the management board of Berlin Heart GmbH here

News-ID: 297883 • Views:

More Releases from Berlin Heart GmbH

1. Japanese EXCOR® Pediatric patient successfully transplanted
Berlin, 19.06.2013: The wait for a donor heart is over for the 1st Japanese patient treated with the EXCOR® Pediatric. On May 20th, 2013 the two-year-old girl was successfully transplanted at Morgan Stanley Childrens Hospital, New York Columbia Presbyterian Medical Center. According to the patient’s physicians, she tolerated the procedure well and is recovering as expected. In August 2012, for the first time in Japan’s history, it was possible
Successful air transport of the first Japanese baby with artificial heart to the …
Berlin, 07.03.2013: For the first time in the history of Japan the physicians Professor Murakami and Professor Ono of the University of Tokyo were able to save the life of an infant with severe heart failure with the help of a Berlin Heart EXCOR® Pediatric ventricular assist device in August 2012. The 21-month-old patient had fallen ill from a dilated cardiomyopathy and was successfully treated for almost six months at
Berlin Medical Technology Companies: State Secretary Nicolas Zimmer visits Berlin Heart
Berlin Medical Technology Companies: State Secretary Nicolas Zimmer visits Berli …
Berlin, 11. October 2012: The State Secretary of the Senate Department for Economics, Technology and Research, Nicolas Zimmer, visited Berlin Heart GmbH in Steglitz last month in order to get acquainted on location with the product line-up, range of application and operating mode of mid-sized Berlin companies. In conversation with the management of Berlin Heart, the present possibilities for therapy of cardiac insufficiency with the ventricular assist device were presented. In
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
Berlin Germany 12 April 2011: The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007,

All 5 Releases


More Releases for Friedel

Global Benzoic acid Market 2019: In-depth Analysis by Regions, Production and Co …
Latest Report Titled on “Benzoic acid Market to 2027 - Global Analysis and Forecasts by Product method (Grignard reagents, Friedel-Crafts reaction, Others); Application (Benzoates, Benzoate plasticizers, Alkyd resins, Benzoyl chloride, Animal feed additive, Others); End use industry (Food and beverages, Chemical, Pharmaceutical, Others) and Geography” Global Benzoic acid Market Research Report analyses the industry status, size, share, trends, growth opportunity, compsetition landscape and forecast to 2027. This report also provides data
Benzoic acid Market Outlook 2019-2027 - Trends, Demand, Production, Sales, Suppl …
Latest Report Titled on “Benzoic acid Market to 2027 - Global Analysis and Forecasts by Product method (Grignard reagents, Friedel-Crafts reaction, Others); Application (Benzoates, Benzoate plasticizers, Alkyd resins, Benzoyl chloride, Animal feed additive, Others); End use industry (Food and beverages, Chemical, Pharmaceutical, Others) and Geography” Global Benzoic acid Market Research Report analyses the industry status, size, share, trends, growth opportunity, compsetition landscape and forecast to 2027. This report also provides data
Benzoic Acid Market Research Key Players: Emerald Performance Materials, Shri Ha …
The global benzoic acid market is expected to grow to a value of USD XXXX million with a CAGR of over XX%, during the forecast period. Benzoic acid is bactericide, fungicide, virucide and viroicide, and is used for disinfection processes. Benzoic acid is naturally available in many plants and animals and can be found in foods and milk products. Food & beverages industry is the dominating user of benzoic acid. Request
Benzoic Acid Market Size Estimation - Industry Trends Report, 2023 by Hebei Smar …
Benzoic Acid Market - Segments By Production Methods: Grignard Reagent and Friedel-Crafts Reaction among others. By Applications: Food & Beverages, Chemicals, Pharmaceuticals, Plastics and Animal Feed among others. By Regions: North America, Europe, APAC and the Rest-of-the-World (RoW). Get a Sample Report for Brief Overview @ https://www.marketresearchfuture.com/sample_request/1119 Segmentation The Global Benzoic Acid Market is majorly segmented on the basis Production Method, Application, and by Regions. Market segmentation based on
Cumene Market Analysis and Forecast Study for 2013 - 2019
Isopropyl-benzene is commonly called as Cumene which is an organic compound generally based on aromatic hydrocarbons with aliphatic substitution. Cumene is a colorless, flammable liquid and having boiling point of 152°C is a constituent of refined fuels and crude oil. Cumene is stable material but shows little instability forming peroxides while storage when comes in contact of air. Industrially cumene is produced by Friedel–Crafts alkylation between benzene and propylene. Mostly
Recent Research: Cumene Market Analysis to 2019
Isopropyl-benzene is commonly called as Cumene which is an organic compound generally based on aromatic hydrocarbons with aliphatic substitution. Cumene is a colorless, flammable liquid and having boiling point of 152°C is a constituent of refined fuels and crude oil. Cumene is stable material but shows little instability forming peroxides while storage when comes in contact of air. Industrially cumene is produced by Friedel–Crafts alkylation between benzene and propylene. Mostly